Search Within

Ryan Nathan Ptashkin

Formats
  1. Meeting Abstract (41)
  2. Journal Article (39)
  3. Research Letter (4)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (80)
  2. GSK Faculty (79)
  3. Human Oncology and Pathogenesis Program (76)
  4. Department of Medicine (74)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (69)
  6. Solid Tumor Oncology Division (59)

More Groups

People
  1. Michael Berger (53)
  2. Ahmet Zehir (50)
  3. Marc Ladanyi (42)
  4. Maria Arcila (31)
  5. Ross Levine (25)
  6. Ryma Benayed (23)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (10)
  4. 2022 (15)
  5. 2021 (8)
  6. 2020 (15)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Modern Pathology (9)
  3. Blood (8)
  4. Clinical Cancer Research (8)
  5. Cancer Research (6)
  6. Journal of Molecular Diagnostics (6)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (13)
  3. Nature Publishing Group (12)
  4. American Society of Hematology (10)
  5. Nature Research (9)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (86)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic and histologic spectrum of SMARCB1-deficient carcinomas of the head and neck including sinonasal tract, thyroid and skin
    Meeting Abstract

    Cotzia, P.; Ptashkin, R.; Gounder, M. M.; Pfister, D. G.; Berger, M. F.; Ladanyi, M.; Ghossein, R.; Antonescu, C. R.; Dogan, S.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Population-scale identification of clonal hematopoiesis derived mutations in solid tumor mutation profiling
    Meeting Abstract

    Ptashkin, R.; Coombs, C. C.; Hyman, D. M.; Solit, D.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; Levine, R. L.; Berger, M. F.; Zehir, A.
    Blood (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas
    Journal Article

    Dogan, S.; Chute, D. J.; Xu, B.; Ptashkin, R. N.; Chandramohan, R.; Casanova-Murphy, J.; Nafa, K.; Bishop, J. A.; Chiosea, S. I.; Stelow, E. B.; more...
    Journal of Pathology (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Chromosome 20q amplification defines a subtype of microsatellite stable, left-sided colon cancers with wild-type RAS/RAF and better overall survival
    Journal Article

    Ptashkin, R. N.; Pagan, C.; Yaeger, R.; Middha, S.; Shia, J.; O'Rourke, K. P.; Berger, M. F.; Wang, L.; Cimera, R.; Wang, J.; more...
    Molecular Cancer Research (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save